1.Table of Contents

2.Information for Readers

3.Jay D. Iams, MD, AJOG Editor

4.Challenging dogma: the endometrium has a microbiome with functional consequences!

5.Evidence that the endometrial microbiota has an effect on implantation success or failure Original Research Article

6.Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management Review Article

7.Accreta placentation: a systematic review of prenatal ultrasound imaging and grading of villous invasiveness Review Article

8.Selective serotonin reuptake inhibitors for depression in pregnancy Original Research Article

9.Please put on your own oxygen mask before assisting others: a call to arms to battle burnout Original Research Article

10.The “virtual” obstetrical intensive care unit: providing critical care for contemporary obstetrics in nontraditional locations Original Research Article

11.Not transabdominal!

12.Transabdominal ultrasound is appropriate

13.Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial Original Research Article

14.Embryo donation: national trends and outcomes, 2000 through 2013 Original Research Article

15.The impact of pregnancy on anti-HIV activity of cervicovaginal secretions Original Research Article

16.Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study Original Research Art

17.Relationship between nongenital tender point tenderness and intravaginal muscle pain intensity: ratings in women with provoked vestibulodynia and implications for treatment Original Research Article

18.Prevalence and factors associated with coinfection of human papillomavirus and Chlamydia trachomatis in adolescents and young women Original Research Article

19.A dynamic quality assessment tool for laparoscopic hysterectomy to measure surgical outcomes Original Research Article

20.Ultrasonographic diagnosis and longitudinal follow-up of recurrences after conservative surgery for borderline ovarian tumors Original Research Article

21.Alcohol, cigarette smoking, and ovarian reserve in reproductive-age African-American women Original Research Article

22.Multifactorial contributors to the severity of chronic pelvic pain in women Original Research Article

23.Long-term functional outcomes following colorectal resection versus shaving for rectal endometriosis Original Research Article

24.Incontinence rates after midurethral sling revision for vaginal exposure or pain Original Research Article

25.Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients Original Research Article

26.Immune activation enhances epithelial nerve growth in provoked vestibulodynia Original Research Article

27.Evaluating the impact of the laborist model of obstetric care on maternal and neonatal outcomes Original Research Article

28.US and territory telemedicine policies: identifying gaps in perinatal care Original Research Article

29.Maternofetal pharmacokinetics and fetal lung responses in chronically catheterized sheep receiving constant, low-dose infusions of betamethasone phosphate Original Research Article

30.Revisiting the challenges of training Maternal Fetal Medicine fellows in chorionic villus sampling Original Research Article

31.The Management of Myelomeningocele Study: obstetrical outcomes and risk factors for obstetrical complications following prenatal surgery Original Research Article

32.Fetal intrapericardial teratoma: natural history and management including successful in utero surgery Original Research Article

33.In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies Original Research Article

34.Early-onset preeclampsia appears to discourage subsequent pregnancy but the risks may be overestimated Original Research Article

35.The interaction between maternal race/ethnicity and chronic hypertension on preterm birth Original Research Article

36.The combination tocolytic effect of magnesium sulfate and an oxytocin receptor antagonist in myometrium from singleton and twin pregnancies Original Research Article

37.Exercise during pregnancy and risk of cesarean delivery in nulliparous women: a large population-based cohort study Original Research Article

38.The predictive value of quantitative fibronectin testing in combination with cervical length measurement in symptomatic women Original Research Article

39.Hospital delivery volume, severe obstetrical morbidity, and failure to rescue Original Research Article

40.Medical and obstetric outcomes among pregnant women with tuberculosis: a population-based study of 7.8 million births Original Research Article

41.Perplexing presentation of uterine prolapse and a prolapsed pedunculated leiomyoma

42.Good eggs and bad eggs

43.Standardization of peak systolic velocity measurement in enhanced myometrial vascularity

44.Selective serotonin reuptake inhibitors and autism: additional data on the Quebec Pregnancy/Birth Cohort

45.Prior uterine evacuation and risk for preterm birth

46.Reply

47.The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age: various objections

48.Reply

49.Medical evacuation of the uterus and subsequent preterm labor

50.Reply

51.The Physician Payments Sunshine Act: a smokescreen if no action!

52.Reply

53.The use of cervical sonography to differentiate true from false labor in term patients presenting for labor check

54.Reply

55.1: Fewer cervical immune cells in women with abnormal vaginal microbiota compared to women with normal vaginal microbiota

56.2: Cervical dysplasia and associated HPV types in a cohort of HIV-positive women

57.3: Cigarette smoking is associated with an altered metabolomic profile of the vaginal environment

58.4: Associations between hormonal contraceptive methods and the vaginal microbiota

59.5: Microbiological etiology of symptomatic versus subclinical pelvic inflammatory disease

60.6: T cell activation in south african HIV-exposed infants linked to ochratoxin exposure

61.7: Relationships between host innate immune genetic variation, bacterial vaginosis, and bacterial colonization

62.8: Detection & implications of lactobacillus iners sub-strain diversity

63.9: Lack of association of gardnerella vaginalis clades with development of bacterial vaginosis

64.10: Perioperative antibiotic regimens and cesarean wound complications among unlabored women

65.11: Factors associated with 30-day readmissions for cesarean delivery surgical site infections

66.12: Modifiable risk factors for endomyometritis after cesarean section in the era of pre-operative antibiotic prophylaxis

67.13: Obstetric complications associated with sepsis

68.14: Neonatal outcomes after maternal sepsis: A population-based cohort study

69.15: To evaluate the efficacy and safety of VT-1161, a potent, highly selective inhibitor of fungal CYP51, in treating women with a documented history of recurrent vulvovaginal candidiasis (RVVC)

70.16: A phase 3 randomized, double-blind, placebo-controlled study to confirm the efficacy and safety of a single, oral dose of SYM-1219, a granule formulation containing 2 grams of secnidazole, for the treatment of bacterial vaginosis

71.17: Time-kill kinetics of the novel echinocandin CD101 for azole-susceptible and -resistant Candida spp. at pH 4 in vagina-simulative medium

72.18: NDV-3A vaccine reduces the frequency of vaginitis in patients with recurrent vulvovaginal candidiasis

73.19: Initial impact of Zika exposure management in pregnancy

74.20: Retrospective review of maternal and neonatal outcomes with discordant histologic and clinical chorioamnionitis in labor

75.21: Prenatal infections and risk of autism, intellectual disability and/or epilepsy

76.22: Outcomes of a negative rapid influenza diagnostic test among pregnant women

77.23: The impact of life-long maternal HIV infection on pregnancy outcomes in women delivering in south carolina

78.24: Maternal immunoglobulin D induced by antepartum vaccination undergoes placental transfer to the fetus

79.25: Mycoplasma genitalium and acute pelvic inflammatory disease

80.1: Associations between serum estrogen, vaginal microbiota and vaginal glycogen in postmenopausal women

81.2: Comparison of three methods for diagnosis of trichomonas vaginalis infections

82.3: Detection of macrolide resistance-mediating mutations among women with mycoplasma genitalium infection in the preventing vaginal infections trial

83.4: Hormonal contraception is associated with stability and lactobacillus-dominance of the vaginal microbiota in a two-year observational study

84.5: Marked increase in cervical CD8 cells following human immunodeficiency virus seroconversion

85.6: Gravidity-dependent associations between interferon response and birth weight in placental malaria

86.7: CD101 Gel formulation is highly efficacious against azole-resistant Candida albicans in a rat model of vulvovaginal candidiasis

87.8: Demographic characteristics, obstetric and neonatal outcomes of pregnant women infected with hepatitis C virus

88.9: Antenatal compliance with ACIP guidelines during three subsequent years following guideline change

89.10: What is normal? deciphering nugent scores of 0-3 in US and Zimbabwean women

90.11: Gonorrhea, chlamydia, and trichomonas and criminal justice involvement among drug-using women in oakland, california

91.12: Incidence and risk factors for catheter-associated urinary tract infection (CAUTI) after cesarean delivery

92.13: Maternal gut microbiome change over pregnancy

93.14: Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole, metronidazole, tinidazole and clindamycin

94.15: Condom knowledge and negotiation in women living with human immunodeficiency virus

95.16: Uropathogens and antibiotic resistance temporal trends among pregnant women: updated assessment and comparison from 2005-2014

96.17: Perinatal outcomes among twin vs singleton pregnancies following previable preterm premature rupture of membranes (PPROM)

97.18: Characteristics of and factors contributing to congenital syphilis cases in georgia: 2000-2009

98.19: Extended spectrum beta-lactamase urinary tract infections during pregnancy

99.20: Post caesarean section surgical site infection surveillance using an online database and mobile phone technology

100.21: Maternal gut microbiome, obesity and gestational weight gain

101.22: Assessing risk factors for poor obstetric outcomes in HIV-infected women in south carolina

102.23: Regional differences in obstetric outcomes among HIV-infected women in a rural state

103.24: Cytokine response after influenza vaccination in pregnant versus nonpregnant women

104.25: Medical complications associated with sepsis in obstetric patients

105.26: Attitudes towards HPV vaccination in young women

106.27: Single-dose clindamycin for bacterial vaginosis: a pooled safety analysis of 3 trials

107.28: Rates of hiv, malaria and tb affecting pregnancies in the unites states, 1998-2011

108.29: Prevalence of cytomegalovirus infection in placentas and umbilical cords with inflammation from unexplained small for gestational age neonates: A pilot study

109.30: The AHNAK-dependent role of chlamydia trachomatis type iii effector protein CT694

110.31: Kaiser permanente maternal infant database: description and pilot study

111.32: Does human immunodeficiency virus impact obstetric and perinatal outcomes? Data from a contemporary southern cohort

112.33: Reaching fetal viability after previable preterm premature rupture of membranes (PPROM)

113.34: Incidence and predictors of re-infection with trichomoniasis based on nucleic acid amplification testing results in HIV-infected patients

114.35: Improved diagnosis of trichomonas by PCR and recommendations for screening practices

115.36: Causes of preterm delivery among HIV-positive women in canada and association with antiretroviral exposure

116.37: Obstetrician/gynecologists: a critical role as vaccinators of adult women

117.38: The impact of hepatitis C on postpartum infection

118.39: Prognosis after preterm premature rupture of membranes (PPROM) for women with history of genital and non-genital infections

119.40: Antibiotic use in previable delivery

120.41: Characterizing women in the U.S. with acute and recurrent vulvovaginal candidiasis and their unmet needs

121.42: Infectious myocarditis in pregnancy: an unlikely cause of respiratory distress

122.43: Development of a maternal outcome definition for international immunization research through the brighton collaboration’s GAIA project

123.44: Disseminated gonococcal infection in pregnancy